Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-24-015606

SVP and General Counsel sold 26,922 shares at $4.50 ($121,079)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Taylor Stacy L · SVP and General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-08-22 Sale : show line 1 in the form 10b5-1 −26,922 $4.50 $121,079 139,365 D
Open-market sales · 26,922 sh · avg $4.50 · $121,079
Loading xslF345X05/form4.xml…